Case report: Robust response of metastatic clear cell sarcoma treated with cabozantinib and immunotherapy

Clear Cell Sarcoma (CCS), also referred to as malignant melanoma of soft parts, is a rare and aggressive malignant tumor. It comprises 1% of all soft tissue sarcomas and is known to be radio- and chemotherapy resistant. CCS shares morphological and immunohistochemical features with malignant melanom...

Descripción completa

Detalles Bibliográficos
Autores principales: Sidlik Muskatel, Rakefet, Pillar, Nir, Godefroy, Jeremy, Lotem, Michal, Goldstein, Gal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582433/
https://www.ncbi.nlm.nih.gov/pubmed/36275056
http://dx.doi.org/10.3389/fped.2022.940927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582433/
https://www.ncbi.nlm.nih.gov/pubmed/36275056
http://dx.doi.org/10.3389/fped.2022.940927

Ejemplares similares